4.8 Article

Mechanism of Shiga Toxin Clustering on Membranes

Journal

ACS NANO
Volume 11, Issue 1, Pages 314-324

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsnano.6b05706

Keywords

Casimir force; fluctuation-induced force; endocytosis; invagination; membrane; clustering glycosphingolipid; lectin

Funding

  1. European Community's Seventh Framework Programme [TRANSPOL-264399]
  2. Agence Nationale pour la Recherche [ANR-09-BLAN-283, ANR-11 BSV2 014 03]
  3. Human Frontier Science Program [RGP0029-2014]
  4. European Research Council [340485]
  5. Fondation ARC pour la Recherche sur le Cancer
  6. Fondation Pierre-Gilles de Gennes
  7. European Research Council (ERC) [340485] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

The bacterial Shiga toxin interacts with its cellular receptor, the glycosphingolipid globotriaosylceramide (Gb3 or CD77), as a first step to entering target cells. Previous studies have shown that toxin molecules cluster on the plasma membrane, despite the apparent lack of direct interactions between them. The precise mechanism by which this clustering occurs remains poorly defined. Here, we used vesicle and cell systems and computer simulations to show that line tension due to curvature, height, or compositional mismatch, and lipid or solvent depletion cannot drive the clustering of Shiga toxin molecules. By contrast, in coarse-grained computer simulations, a correlation was found between clustering and toxin nanoparticle-driven suppression of membrane fluctuations, and experimentally we observed that clustering required the toxin molecules to be tightly bound to the membrane surface. The most likely interpretation of these findings is that a membrane fluctuation-induced force generates an effective attraction between toxin molecules. Such force would be of similar strength to the electrostatic force at separations around 1 nm, remain strong at distances up to the size of toxin molecules (several nanometers), and persist even beyond. This force is predicted to operate between manufactured nanoparticles providing they are sufficiently rigid and tightly bound to the plasma membrane, thereby suggesting a route for the targeting of nanoparticles to cells for biomedical applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available